Cellcept and Zolpidem tartrate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Zolpidem tartrate (zolpidem tartrate). Common drug interactions include haemorrhagic cerebral infarction among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Cellcept and Zolpidem tartrate. It is created by eHealthMe based on reports of 99 people who take the same drugs from the FDA, and is updated regularly.
What is Cellcept?
Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.
What is Zolpidem tartrate?
Zolpidem tartrate has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 32,177 Zolpidem tartrate users. Check the latest studies of Zolpidem tartrate.
99 people who take Cellcept and Zolpidem tartrate together, and have interactions are studied.

What are the common drug interactions of Cellcept and Zolpidem Tartrate, by gender? *:
female:
- Haemorrhagic cerebral infarction (brain stroke with bleeding)
- Hypertension (high blood pressure)
- Pruritus (severe itching of the skin)
- Pyrexia (fever)
- Renal failure (kidney dysfunction)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Vomiting
- Protein urine
- Renal cancer (cancer of kidney)
- Stomatitis (inflammation of mucous membrane of mouth)
male:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Abdominal pain
- Blood creatinine increased
- Depression
- Diarrhoea
- Dysuria (painful or difficult urination)
- Fatigue (feeling of tiredness)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Neoplasm (tumour)
What are the common drug interactions of Cellcept and Zolpidem Tartrate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Infection
- Pneumonia cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses)
- Renal failure acute (rapid kidney dysfunction)
- Transplant rejection (a transplant material is not worked)
20-29:
- Oesophagitis (inflammation of oesophagus)
- Transplant rejection (a transplant material is not worked)
30-39:
- Renal failure (kidney dysfunction)
- Chronic kidney disease
- Depression
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Depressed level of consciousness
- Pyrexia (fever)
- Abdominal pain
- Cytomegalovirus infection
- Decreased appetite
40-49:
- Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue)
- Myocarditis (inflammation of heart muscle myocardium)
- Cytomegalovirus viraemia (cytomegalo virus in blood stream)
- Chronic kidney disease
- Dyspnoea (difficult or laboured respiration)
- Haemorrhagic cerebral infarction (brain stroke with bleeding)
- Bone marrow failure
- Urinary tract infection
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Cough
50-59:
- Hypokalaemia (low potassium)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Protein urine present
- Abdominal discomfort
- Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
- Anaemia (lack of blood)
- Atypical femur fracture
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
- Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
- Compression fracture (fracture due to pressure caused by injury)
60+:
- Asthenia (weakness)
- Weight decreased
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Chronic kidney disease
- Death
- Diarrhoea
- Dysstasia (difficulty in standing)
- Eye swelling
- Eyelid oedema (eyelids are swollen and contain excessive fluid)
- Fatigue (feeling of tiredness)
What are the existing conditions these people have? *
- Constipation: 13 people, 13.13%
- Pain: 9 people, 9.09%
- High Blood Pressure: 8 people, 8.08%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.07%
- High Blood Cholesterol: 6 people, 6.06%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 5.05%
- Osteoporosis (bones weak and more likely to break): 5 people, 5.05%
* Approximation only. Some reports may have incomplete information.
Do you take Cellcept and Zolpidem tartrate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cellcept (41,872 reports)
- Zolpidem tartrate (32,177 reports)
Browse all drug interactions of Cellcept and Zolpidem tartrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cellcept:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zolpidem tartrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cellcept and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zolpidem tartrate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on mycophenolate mofetil and zolpidem tartrate (the active ingredients of Cellcept and Zolpidem tartrate, respectively), and Cellcept and Zolpidem tartrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Vyvanse cause Thermal Burn? - 9 seconds ago
- Percocet vs. Zantac 150, side effect and effectiveness comparison - 13 seconds ago
- Could Allegra cause Itching? - 15 seconds ago
- Drug interactions of Celebrex and Coreg - 35 seconds ago
- Chronic Obstructive Pulmonary Disease and Cervix Carcinoma - 35 seconds ago
- Could Lorazepam cause Liver Injury? - 42 seconds ago
- Drug interactions of Krill Oil and Promethazine - 48 seconds ago
- Could Amlodipine Besylate cause Eye Pain? - 50 seconds ago
- Could Vimpat cause Haemorrhage? - 56 seconds ago
- Drug interactions of Kevzara and Emgality - 57 seconds ago